Topic Review
Insulin
Insulin is used for the treatment of diabetes mellitus, which is characterized by hyperglycemia. Subcutaneous injections are the standard mode of delivery for insulin therapy; however, this procedure is very often invasive, which hinders patient compliance, particularly for individuals requiring insulin doses four times a day. Furthermore, cases have been reported of sudden hypoglycemia occurrences following multidose insulin injections. Such an invasive and intensive approach motivates the quest for alternative, more user-friendly insulin administration approaches. For example, transdermal delivery has numerous advantages, such as prolonged drug release, low variability in the drug plasma level, and improved patient compliance.
  • 1.1K
  • 05 Feb 2021
Topic Review
Interactions of Analgesics with Cisplatin
Cisplatin (CDDP), one of the most eminent cancer chemotherapeutic agents, has been successfully used to treat more than half of all known cancers worldwide. Despite its effectiveness, CDDP might cause severe toxic adverse effects on multiple body organs during cancer chemotherapy, including the kidneys, heart, liver, gastrointestinal tract, and auditory system, as well as peripheral nerves causing severely painful neuropathy. The latter, among other pains patients feel during chemotherapy, is an indication for the use of analgesics during treatment with CDDP. Different types of analgesics, such as acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDS), and narcotic analgesics, could be used according to the severity of pain. Administered analgesics might modulate CDDP’s efficacy as an anticancer drug. NSAIDS, on one hand, might have cytotoxic effects on their own and few of them can potentiate CDDP’s anticancer effects via inhibiting the CDDP-induced cyclooxygenase (COX) enzyme, or through COX-independent mechanisms. On the other hand, some narcotic analgesics might ameliorate CDDP’s anti-neoplastic effects, causing chemotherapy to fail. Concerning safety, some analgesics share the same adverse effects on normal tissues as CDDP, augmenting its potentially hazardous effects on organ impairment.
  • 276
  • 14 Jan 2022
Topic Review
Interplay between Drugs and Mycotoxins
Mycotoxin contamination is a global food safety issue leading to major public health concerns. Repeated exposure to multiple mycotoxins not only has repercussions on human health but could theoretically also lead to interactions with other xenobiotic substances—such as drugs—in the body by altering their pharmacokinetics and/or pharmacodynamics. The combined effects of chronic drug use and mycotoxin exposure need to be well understood in order to draw valid conclusions and, in due course, to develop guidelines.
  • 584
  • 21 Dec 2022
Topic Review
Interstitial Lung Diseases
Interstitial lung diseases (ILD) are a heterogeneous group of pulmonary disorders characterized by varying degrees of inflammation and fibrosis resulting in the loss of alveolar function and impairment of gas exchange.
  • 416
  • 30 Dec 2022
Topic Review
Interventional Methods against Neuropathic Pain
Neuropathic pain affects more than one million people across the globe. The quality of life of people suffering from neuropathic pain has been considerably declining due to the unavailability of appropriate therapeutics. Available treatment options can only treat patients symptomatically, but they are associated with severe adverse side effects and the development of tolerance over prolonged use. Continuous efforts are evident, aiming to develop novel interventions with better efficacy instead of symptomatic treatment. Available pharmacotherapeutics are unable to manage pain on a long-term basis and patients are developing resistance and tolerance to pain management medications over time; therefore, it is necessary to investigate non-pharmacological or interventional approaches. Interventional treatments, including nerve blocks or surgeries for targeted drug delivery, or specific neural modulation, provide alternate strategies in refractory cases.
  • 305
  • 11 Aug 2022
Topic Review
Intestinal Permeability
The intestinal epithelial barrier consists of multiple elements that contribute to its function as a physical, chemical, and immunological defense. While the mucus layer, intestinal epithelium, and the underlying immune cells in the lamina propria comprise a major component of the defense response, intestinal epithelial permeability is regulated by tight junctions.
  • 831
  • 03 Sep 2021
Topic Review
Intranasal Insulin in Ischemia, Brain Injuries and Diabetes
A decrease in the activity of the insulin signaling system of the brain leads to neurodegeneration and impaired regulation of appetite, metabolism, and endocrine functions. This is due to the neuroprotective properties of brain insulin, its leading role in maintaining glucose homeostasis in the brain, as well as in the regulation of the brain signaling network responsible for the functioning of the nervous, endocrine and other systems. One of the approaches to restore the brain insulin system is the use of intranasally administered insulin (INI). INI is being considered as a promising drug to treat Alzheimer's disease and mild cognitive impairment. Clinical application of INI is being developed for the treatment of other neurodegenerative diseases and improve cognitive abilities in stress, overwork, and depression. It has been shown that INI can be used for the treatment of cerebral ischemia, traumatic brain injuries, postoperative delirium, as well as diabetes mellitus and its complications, including dysfunctions in the gonadal and thyroid axes.
  • 521
  • 20 Apr 2023
Topic Review
Intrathecal Pseudodelivery of Drugs for Neurodegenerative Diseases
Intrathecal pseudodelivery of drugs is a novel route to administer medications to treat neurodegenerative diseases based on the cerebrospinal fluid (CSF)-sink therapeutic strategy by means of implantable devices. 
  • 337
  • 10 Mar 2023
Topic Review
Intravitreal Delivery Systems for Sustained Drug Release
Slow-release delivery systems are needed to ensure long-term sustained treatments for retinal diseases such as age-related macular degeneration and diabetic retinopathy, which are currently treated with anti-angiogenic agents that require frequent intraocular injections. These can cause serious co-morbidities for the patients and are far from providing the adequate drug/protein release rates and required pharmacokinetics to sustain prolonged efficacy.
  • 640
  • 17 May 2023
Topic Review
Intrinsic and Acquired Chemotherapy Resistance
Drug resistance is a commonly unavoidable consequence of cancer treatment that results in therapy failure and disease relapse. Intrinsic (pre-existing) or acquired resistance mechanisms can be drug-specific or be applicable to multiple drugs, resulting in multidrug resistance.
  • 1.2K
  • 23 Feb 2021
  • Page
  • of
  • 106
Video Production Service